806
A. Morin Deveau, T. L. Macdonald / Tetrahedron Letters 45 (2004) 803–807
ensure vigorous stirring during BuLi addition. After the
addition of BuLi, the reaction was stirred for 15 min at
)78 ꢁC, then triisopropyl borate (3 equiv) was added in
one portion. The reaction was allowed to warm to room
temperature over 6 h and then stirred for an additional
12 h. The reaction was cooled to 0 ꢁC, then carefully
acidified to pH ¼ 5–6 with ammonium chloride (satd)
and/or HCl (5%). The THF was then removed in vacuo
and the aqueous residue diluted with CH2Cl2. The acidic
aqueous layer was subsequently extracted three times
with CH2Cl2. The combined organics from this extrac-
tion were then dried over MgSO4, filtered, and concen-
trated. The crude boronic acid was used immediately
without further purification.
Supplementary data, including synthetic protocols and
spectral data for 4.66–4.67a–c, is available online with
the paper in ScienceDirect.
References and notes
1. For the anti-mitotic properties of the combretastatins see:
(a) Lin, C. M.; Ho, H. H.; Pettit, G. R.; Hamel, E.
Biochemistry 1989, 28, 6984–6991; (b) Sackett, D. L.
Pharmacol. Therap. 1993, 59, 163–228.
2. For clinical significance of the combretastatins in cancers
see: (a) Hill, S. A.; Tozer, G. M.; Pettit, G. R.; Chaplin, D.
J. Anticancer Res. 2002, 22, 1453–1458; (b) Adams, J.;
Elliott, P. J. Oncogene 2000, 19, 6687–6692; (c) Prise, V. E.;
Honess, D. J.; Stratford, M. R. L.; Wilson, J.; Tozer, G.
M. Int. J. Oncol. 2002, 21, 717–726.
4. Arylation of 5-bromo-2-methoxytropolone via
ligandless Suzuki cross-coupling
3. Brown, M. L.; Rieger, J. M.; Macdonald, T. L. Bioorg.
Med. Chem. 2000, 8, 1433–1441.
4. Malawista, S. E. Arthritis Rheum. 1968, 11, 191–197.
5. Folpini, A.; Furfori, P. J. Toxicol., Clin. Toxicol. 1995, 33,
71–77.
6. For leading references see: Dustin, P. Microtubules;
Springer: New York, 1984.
7. (a) Fitzgerald, T. J. Biochem. Pharmacol. 1976, 25,
1383–1387; (b) Morin Deveau, A. Doctoral Disserta-
tion, University of Virginia, Charlottesville, VA, May
2002.
8. Badone, D.; Baroni, M.; Cardamone, R.; Ielmini, A.;
Guzzi, U. J. Org. Chem. 1997, 62, 7170–7173.
9. For leading Suzuki coupling references see: (a) Miyaura,
N.; Suzuki, A. Chem. Rev. 1995, 95, 2457–2483; (b)
Suzuki, A. J. Organomet. Chem. 1999, 576, 147–168; (c)
Kotha, S.; Lahiri, K.; Kashinath, D. Tetrahedron 2002, 58,
9633–9695.
10. For leading references on solid-phase Suzuki coupling see:
(a) Bork, J. T.; Lee, J. W.; Chang, Y. T. Tetrahedron Lett.
2003, 44, 6141–6144; (b) Brase, S.; Kirchhoff, J. H.;
Kobberling, J. Tetrahedron 2003, 59, 885–939.
11. Last, L. A.; Fretz, E. R.; Coates, R. M. J. Org. Chem.
1982, 47, 3211–3219.
To a 5 mL round bottom flask equipped with a reflux
condenser, 5-bromotropolone (1 equiv), boronic acid
(1.01 equiv), Pd(OAc)2 (0.2 equiv), K2CO3 (2.5 equiv),
NBu4Br (1 equiv), and water (doubly distilled, degassed
for 24 h by bubbling argon gas through, 0.90 M in
boronic acid) were added. The reaction was heated to
70 ꢁC and allowed to stir until TLC analysis indicated
that all tropolone was consumed (usually 5–30 min,
always less than 1 h). The dark brown/black reaction
mixture was cooled to room temperature, diluted with
water, and extracted with CH2Cl2 (3·). The combined
organics were washed with brine and dried over MgSO4
before being filtered through a pad of Celite and con-
centrated in vacuo. Unless otherwise noted, the crude
solid was purified by preparative TLC, and then crys-
tallized from hexanes/EtOAc to afford the desired
functionalized biaryl.
12. VanRheenen, V.; Kelly, R. C.; Cha, D. Y. Tetrahedron
Lett. 1976, 23, 1973–1976.
5. Conclusion
13. Amon, C. M.; Banwell, M. G.; Gravatt, G. L. J. Org.
Chem. 1987, 52, 4851–4855.
14. Banwell, M. G.; Onrust, R. Tetrahedron Lett. 1985, 26,
4543–4546.
15. Banwell, M. G.; Lambert, J. N.; Reum, M. E.; Onrust, R.
Org. Prep. Proced. Int. 1988, 20, 393–399.
16. A complex mixture of starting material and brominated
products was obtained.
17. Stork, G.; Takahashi, T. J. Am. Chem. Soc. 1977, 99,
1275–1276.
18. Alo, B. I.; Kandil, A.; Patil, P. A.; Sharp, M. J.; Sidiqui,
M. A.; Snieckus, V.; Josephy, P. D. J. Org. Chem. 1991,
56, 3763–3768.
19. Mattson, R. J.; Sloan, C. P.; Lockhart, C. C.; Catt, J. D.;
Gao, Q.; Huang, S. J. Org. Chem. 1999, 64, 8004–8007.
20. (a) Bussolari, J. C.; Rehborn, D. C. Org. Lett. 1999, 1,
965–967; (b) Hesse, S.; Kirsch, G. Synthesis 2001, 755–
758.
We contend that ACÕs anti-mitotic properties coupled
with its structural similarity to the combretastatins and
its synthetically accessible core make biaryl colchici-
noids justifiable targets that may generate new leads in
cancer chemotherapy. Overall, we successfully applied
BadoneÕs ligandless Suzuki cross-coupling (Pd(OAc)2,
TBAB, K2CO3, water) to join 5-bromo-2-methoxy-
tropolone and a series of aryl boronic acids functional-
ized with 30,40-methylene- or benzodioxy-ethers (Scheme
2). In this work, eight new AC colchicinoids containing
30,40-catechol ethers were ultimately realized (4.66–
4.67a–d) (Scheme 2 and Table 1). With control of con-
centration and extensive solvent degassing, the time
required for the Suzuki reaction could be lowered to
5 min, but in all cases less than 1 h. We think that both
the use of water as a solvent and the abbreviated reac-
tion time make these Suzuki cross-coupling conditions
attractive for future synthetic applications, such as high-
throughput production of colchicinoids and other
functionalized biaryl heterocycles.
21. Supplementary spectral data accompanies this article
online (ScienceDirect).
22. Importantly, unwanted cross-coupled by-products derived
from residual aryl bromides did not contaminate our final
colchicinoids. If any biaryl by-products were indeed